NCT05156125

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

The Induction and Long-Term Extension Periods were completed and analyzed as planned. The Sponsor decided to terminate clinical conduct in the Open-Label Extension Period. The decision to terminate the study was not due to safety concerns.